Comparison of cytotoxicity chitosan- docetaxel nanoparticles and free drug on MDA-MB-231 breast cancer cells

Abstract:
Background And Objective
Resulting in the accumulation of somatic mutations in cancer cells caused. Breast cancer is the most commonly diagnosed cancer among women worldwide. The use of nanoscale drug delivery systems is important for effective treatment. The main aim of this study was to determine effects of chitosan conjugated to docetaxel nanoparticles in treatment of breast cancer.
Methods
The self-assembled nanoparticle were prepared though conjugation of docetaxel , using succinic anhydride as a linker. Conjugation was confirmed by nuclear magnetic resonance spectroscopy (1H-NMR) studies. Evaluation of the in vitro cytotoxicity of the nanoparticles by MTT assay.
Results
The results indicated that prepared nanoparticles have spherical shape with narrow size distribution around 150 nm with positive zeta potential. Acording to in vitro studies, we observed increased cell death in treat by nanoparticles
Conclusion
Our finding show that docetaxel-chitosan nanoparticles can be suggested as an effective anticancer combination for breast cancer treatment.
Language:
Persian
Published:
Razi Journal of Medical Sciences, Volume:23 Issue: 3, 2016
Pages:
9 to 18
https://magiran.com/p1555663  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!